Give Men Life-Saving Prostate Cancer Checks at 45, Urges Charity


Give Men Life-Saving Prostate Cancer Checks at 45, Urges Charity

Olympic Legend Sir Chris Hoy Sparks NHS Review

A charity is pushing for men at high risk of developing prostate cancer to undergo screening from the age of 45. This call comes after Sir Chris Hoy's own battle with the disease and his suggestion that men should get checked in their forties.

NHS Review Prompted by Sir Chris Hoy's Diagnosis

Sir Chris Hoy's revelation that a "little" pain in his shoulder was the only symptom of his cancer has reignited the conversation around prostate cancer testing. His call for lowering the standard screening age to 45 has prompted Health Secretary Wes Streeting to look into the matter.

Charity Advocates for National Prostate Cancer Screening Programme

Prostate Cancer Research is advocating for a nationwide screening programme where men between 50 and 69 would be routinely checked for the disease, while those at higher risk would start screening at 45. This initiative aims to address the lack of a national screening programme for prostate cancer, which claims over 12,000 lives annually.

Improved Screening Could Save Lives

The charity believes that earlier screening could lead to fewer deaths and reduce late-stage diagnoses. By implementing a targeted approach involving letters, text messages, PSA tests, MRIs, and biopsies, more men could be diagnosed early, increasing their chances of survival.


Give Men Life-Saving Prostate Cancer Checks at 45, Urges Charity

Challenges with PSA Testing

While the PSA test is a simple blood test, its reliability has been questioned. Elevated PSA levels can indicate prostate cancer, but they can also be elevated due to non-cancerous conditions like an enlarged prostate or infections. Prostate Cancer Research advocates for a multi-test approach to avoid over-diagnosis and over-treatment.

Potential Economic Benefits of Screening

Aside from the moral argument, the charity's report aims to demonstrate the economic benefits of screening for prostate cancer. By diagnosing individuals early, the UK could see a net economic benefit of £100 million, with a 100% chance of survival at stage 1.